Interestingly, CDCA2 not only enhances the proliferation of CRC cells by activating the AKT/CCND1 pathway but also reduces the radiosensitivity of gastric adenocarcinoma by activating the PI3K/AKT pathway [45,46]. This evidence concerns the gene CDCA2 and colorectal carcinoma.